Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02FEV
|
||||
Former ID |
DIB014340
|
||||
Drug Name |
S-8921
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Phase 2 | [534690] | ||
Company |
Shionogi & Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C30H36O9
|
||||
Canonical SMILES |
c1(c(c(c2c(c1O)cc(c(c2OC)OC)OC)c1cc(c(cc1)OC)OC)C(=O)OC<br />)C(=O)CC(CC)CC
|
||||
CAS Number |
CAS 151165-96-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Ileal bile acid transfer | Target Info | Inhibitor | [534690] | |
KEGG Pathway | Bile secretion | ||||
Reactome | Recycling of bile acids and salts | ||||
WikiPathways | Bile acid and bile salt metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.